breast cancer. To bring much-needed treatment options to patients with triple-negative breast cancer, an aggressive form of breast cancer, AstraZeneca is collaborating with Daiichi Sankyo to evaluate the potential of datopotamab deruxtecan-dlnk...
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025. In this role, Beth...
waiting list in the U.S., representing 86% of the national transplant list. In 2024, 27,761 kidney transplants were performed, highlighting the urgent need for innovative solutions to address the organ shortage. "This hundredth KidneyVault case is...
solid tumor patients refractory to prior treatments. The two drugs are derived from HighField’s proprietary ADCplexTM platform, containing chemotherapy payloads inhibiting Topoisomerase I and Topoisomerase II activities respectively. HF158K1 (K1)...
adoption of pharmacogenomics (PGx) in healthcare. The collaboration will focus on exploring the potential of PGx to transform healthcare delivery, aiming to enhance patient outcomes through precision medicine. PGx works by tailoring drug choice and...
B.V. (BAH). New investors Invest-NL, and the European Innovation Council (EIC) joined existing backers Oost NL and informal angels in the round. The funding accelerates the development of AMT’s ELANA® Heart Bypass System, a minimally invasive...
full Inscopix ecosystem with unique ProView Integrated 2P Lenses, the nVision behavioral acquisition unit, the IDEAS platform (including suite2p and CalmAn for specialized two-photon calcium imaging analysis), and Inscopix Data Processing Software...
and quantitation with triple-quad MS selectivity and multiple-reaction monitoring (MRM) capabilities. The ClinDART® platform also improves sustainability with a 95% reduction in solvent use, lower cost, and increased laboratory productivity....
biomedicines affordable and accessible to all patients globally, fulfilling our commitment to human health. For more information, please visit www.chimebiologics.com.
implications for improving diagnosis and treatment in oncology. Traditional methods of tissue sampling offer limited information on a tumor. Methods using 3D pathology can not only identify cases previously classified as "false negatives" but also...
using CM&S, enables precise prediction of mechanical behavior of the implants in the body, as well as provides information about degradation kinetics, tissue remodeling and interaction with the host tissue. These smart tools are reducing the need...
Fund (MRFF) Frontiers Initiative, the goal of the multidisciplinary multi-institutional investigator team is to transform the clinical management of prostate cancer by leveraging leading therapeutic radiopharmaceutical technology paired innovative...
and development activities, the Company is exploring strategic alternatives to maximize stockholder value. For more information, please visit, www.exicuretx.com.
reinvestment by TPG Asia and investment from GIC and Temasek will allow Novotech to pursue further organic growth and transformative M&A opportunities. This is part of Novotech’s ambition to become the first truly global biotech-focused CRO....
epidemiology and hospital acquired infection (HAI) tracing. Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s...
Illinois Retina Associates and Rush University Medical Center. "Eliminating the need for intraocular gas would be transformative for patients undergoing vitrectomy, addressing a significant source of patient anxiety." "We are thrilled to complete...
and precision medicine services. As part of this collaboration, Precision for Medicine will integrate the SOPHiA DDM™ Platform for biomarker discovery, clinical trial assays (CTAs), and advanced algorithms to expand clinical trial capabilities....
hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages. This innovative product line addresses the industry’s concern with nitrosamine...
is Greg Kalemkerian, MD, a renowned thoracic oncologist at the University of Michigan. "Small cell lung cancer remains a formidable challenge with few effective therapies for patients who relapse or don't respond to initial treatment," said Dr....
of Hello Heart. “But the status quo won’t get us there — we need innovation. We will continue building on our platform with products like Hello Heart Pill Box to engage people in their heart health like never before.” About Hello Heart: Hello Heart...
